Source: Annual Congress 2009 - Lung cancer biology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
E. Karetsi, T. Kerenidi, M. Ioannou, G. Koukoulis, K. Gourgoulianis, P. A. Molyvdas, E. Paraskeva (Larissa, Greece). Clinical significance of hypoxia inducible factor-1α and VEGF expression in lung cancer. Eur Respir J 2009; 34: Suppl. 53, 283

Member's Comments

No comment yet.

Related content which might interest you: Clinical significance of serum survivin, MGB-1 and Pref-1 levels during chemotherapy of lung cancer Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Clinical significance of serum osteopontin levels in lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Prognostic significance of serum vascular endothelial growth factor and angiopoietin-2 in lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Expression of vascular endothelial growth factor (VEGF) and its receptors (VEFG-R1-Flt1, VEGF-R2-Flk1) in non small cell lung carcinomas (NSCLC): correlation with lymphangiogenesis and clinical outcome Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007 EGFR and hTERT mRNA expression in non-small cell lung cancer patients – Diagnostic and prognostic implications Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Prognostic significance of the expressions of Axl and/or Gas6 in patients with completely resected lung adenocarcinoma Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 The clinical significance of soluble E-cadherin in lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 769s Year: 2006 Prognostic significance of epidermal growth factor receptor expression in nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002 Distribution of BCL-2 gene expression and its prognostic value in non-small cell pulmonary cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002 Increased vascular-endothelial growth factor a (VEGF-A) expression and response to angiogenesis inhibitor erlotinib in non-small-cell lung cancer (NSCLC) – hint for a new predictive marker? Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007 Expression of vascular endothelial-cadherin and vascular endothelial growth factor in non-small cell lung cancer and their clinical significances Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Adenovirus-mediated AP-2α down-regulates MnSOD expression in lung cancer A549 cells and its molecular mechanism Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011 The effects of hypoxia on the expression of MMP-2, MMP-9 in human lung adenocarcinoma A549 cells Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Prognostic value of p21 protein expression in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 Hypoxia inducible factor-1 alpha (HIF-1 alpha) expression was correlated with the survival in patients with small cell lung cancer (SCLC) Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 The effect of SDF-1/CXCR4 on expression of VEGF and MMP-9 in small cell lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Clinical evaluation of the plasma levels of hTERT and EGFR expression as markers for early detection of non-small cell lung cancer Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009 microRNA-34a and microRNA 199a-5p in COPD and their control of HIF-1α expression in pulmonary vasucular endothelial cells Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Prognostic significance of MUC1 expression in resected lung adenocarcinoma Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Immunohistochemical expression of nuclear factor kappa-B/p65 and cyclooxygenase-2 in non-small cell lung cancer patients: Prognostic value and impact on survival Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014